Status:
RECRUITING
Building of a Diagnostic/Prognostic Database for Human ERG Variant Effects
Lead Sponsor:
Nantes University Hospital
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Centre National de la Recherche Scientifique, France
Conditions:
Long QT Syndrome
Eligibility:
All Genders
Brief Summary
Cardiac channelopathies induce severe heart rhythm or conduction disorders. Mutations of the KCNH2 gene, that encodes the human (h) ERG channel, is responsible for 30-40% of all cases of long QT syndr...
Eligibility Criteria
Inclusion
- Patients carrier of a mutation in KCNH2 gene
Exclusion
- Patients who refuse to take part to research
Key Trial Info
Start Date :
September 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 24 2026
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06087367
Start Date
September 20 2021
End Date
March 24 2026
Last Update
May 23 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes university hospital
Nantes, Loire-atlantique, France, 44093
2
Hôpital Bichat - Claude Bernard
Paris, France, 75018